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Ya clinical trial under way (clinicaltrials.gov ID: NCT02176265), such surfaces
may offer safe alternatives to DES, particularly in patients in whom rapid healing is
crucial.
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BACKGROUND There have been limited data comparing efﬁcacy and safety of Bio-
limus-eluting Stents (BES, BiomatrixTM, Biosensors and NoboriTM, Terumo) with
Zotarolimus-eluting Stent (ZES, Resolute Integrity, Medtronic) in a series of Asian
population in real world clinical practice.
METHODS A total of 626 patients (pts) receiving BES or ZES were pooled from our
prospective percutaneous coronary intervention (PCI) registry from March 2008 to
May 2013. To adjust potential confounders, a propensity score matched (PSM) anal-
ysis was performed using the logistic regression model, and clinical outcomes were
compared between the two groups up to 12-month.
RESULTS After PSM analysis, 2 propensity-matched groups (135 pairs, n ¼ 270 pts,
C-statistic¼0.809) were generated and the baseline characteristics of the two groups
were balanced. At six to 9-month angiographic and Two-year clinical outcomes, there
were similar incidence of binary in-stent restenosis and hard endpoints including
mortality, myocardial infarction, target lesion revascularization (TLR), target vessel
revascularization (TVR), non-target vessel revascularization (NTVR) and major
adverse cardiac events (MACEs,Table).
CONCLUSIONS In our study, BES showed similar efﬁcacy and safety compared with
ZES up to 12-months in a series of Asian population in real world clinical practice.
Table. Mid-term angiographic and 12-month Clinical Outcomes after propensity score matched analysisIMAGING MODALITIES
CRT-706
Development Of Non-invasive Coronary Wave Intensity Analysis
Christopher Broyd,1 Sukhjinder Nijjer,1 Sayan Sen,1 Ricardo Petraco,1 Rasha Al-Lamee,1
Nicolas Foin,1 Mahmood Al-Bastami,2 Amarjit Sethi,2 Rafﬁ Kaprielian,2 Iqbal Malik,2
Darrel Francis,1 Kim Parker,1 Alun Hughes,3 Ghada W. Mikhail,2 Jamil Mayet,2
Justin Davies11Imperial College London, London, United Kingdom; 2Imperial College London NHS
Trust, London, United Kingdom; 3University College London, London, United Kingdom
BACKGROUND Wave Intensity Analysis (WIA) has found particular applicability in
the coronary circulation where it is able to quantify and qualify the energy affecting
blood ﬂow. The most important wave for the regulation of coronary blood ﬂow is the
backward-travelling decompression wave (BDW). Until now, coronary WIA has always
been calculated from invasive measures of pressure and ﬂow. However, recently it
has become feasible to obtain coronary pressure and ﬂow waveforms non-invasively.
In this study we set out to validate non-invasive coronary wave intensity at rest and
under exercise conditions.
METHOD AND RESULTS 22 patients (mean age 6012, 14 male) with unobstructed
coronary arteries, underwent invasive WIA in the left anterior descending artery.
Immediately afterwards, non-invasive coronary ﬂow and pressure were recorded and
WIA calculated from pulsed-wave Doppler echocardiography and brachial supra-
systolic blood pressure. 9 of these patients also underwent non-invasive WIA
assessment during a standardized exercise regimen.
A consistent pattern of 6 predominating waves were observed both invasively and
non-invasively with a very similar BDW (peak: -13.87.9 vs -14.97.2 x 104 Wm-2s-2,
cumulative -6.54.0 vs -6.22.9 x 103 Wm-2s-1). As has been previously seen inva-
sively, left ventricular hypertrophy was correlated with a decreasing percentage BDW
(r¼-0.52, p¼0.01) and exercise produced a rise in the BDW: at maximum exercise the
peak BDW increased from 10.06.5 to 30.220.4x 104 Wm-2s-2 (p¼0.02) and cumu-
lative from 5.43.8x103 to 14.58.9x103 Wm-2s-1 (p¼0.03).
CONCLUSION Coronary wave intensity analysis can be reliably measured non-inva-
sively and responds appropriately in physiological and pathological settings. This has
potential to simplify WIA assessments and increase its applicability.CRT-707
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BACKGROUND Differentiation of dysfunctional but viable myocardium from irre-
versibly damaged scar tissue has important clinical implications for patients’ ischemic
heart disease and impaired left ventricular function.
METHODS We studied 27 male patients with ischemic cardiomyopathy (Age: 607
years) before and after low dose dobutamine echocardiography (LDDE). Mitral
annular isovolumic contraction velocity (IVV) was obtained from septal, lateral,
anterior and inferior mitral annuli. Wall motion score index (WMSI) was averaged
from 18 segments in apical views. Global viability was considered if enhanced motion
occurred in 2 segments. Difference between post and pre-LDDE IVV and WMSI were
calculated as d-IVV and d-WMSI.
RESULTS 486 segments were assessed. 14 segments were normal, and 472 were
abnormal, of which 67 (14%, 33 basal, 22 mid, and 12 apical) had enhanced motion
post-LDDE. Global WMSI decreased post compared to pre-LDDE (2.330.36 vs.
2.460.21, p¼0.07). IVV increased post-LDDE (6.14.7 vs. 3.71.6 cm/s, p¼0.01). IVV
of different annular positions increased similarly. IVV correlated after LDDE with
global WMSI (r¼ -0.43, p¼0.028), and d-SWMI correlated with d-IVV (-0.43, p¼0.02).
12 patients (44%) showed global viability, for whom d-IVV was higher than patients
without viability (4.1SE 1.17 vs. 1.16SE 0.59 cm/s, p¼0.02). Walls with enhanced
motion had higher d-IVV from the corresponding mitral annular position (4.7SE0.84
vs. 1.9SE0.33 cm/s, p¼0.002) and wall speciﬁc d-WMSI correlated with the d-IVV of
the corresponding mitral annular position (r¼0.43, p<0.001). Post LDDE IVV showed
no signiﬁcant difference when only basal segments showed enhanced motion post
LDDE compared to those who did not (p¼0.134). While, post LDDE IVV was higher
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Ywhen enhanced motion occurred in mid or apical segments than when they did not
(p¼0.01, 0.005, respectively). d-IVV correlated with d-WMSI of the mid and apical
levels (r¼0.48, 0.42, p¼0.01, 0.03), while it did not for the basal level (r¼0.21, p¼0.3).
ROC-curve showed that d-IVV detects global viability effectively (AUC¼0.761), how-
ever, sensitivity and speciﬁcity increased for mid and apical levels (AUC¼0.790,
0.868).
CONCLUSION Mitral annular longitudinal motion during isovolumic contraction,
represented by IVV and d-IVV, increase after LDDE in the presence of viable
myocardium. Changes that occur in the mid and apical segments of the LV seem to
contribute more to this effect than the basal segments.OTHER
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BACKGROUND Smartphone applications (apps) in healthcare are being increasingly
developed with the aim of beneﬁting both patients and their physicians. The delivery
of adequate instructions both before and after a procedure is important in ensuring
the best outcome for patients. Failure to comply with instructions after a procedure
can increase the risk of complications.
STUDY We conducted a prospective evaluation of a new smartphone app designed to
provide pre- and post-operative instructions (TrackMyRecovery). The app also
permitted patients to securely send images of their wound and pain scores. The
primary end points were patients’ compliance with reading instructions, sending
wound images and pain levels. The secondary endpoint was any post-procedural
related complications.
METHODS The instructions were tailored according to the physician’s preferences
and were associated with reminders in the form of push notiﬁcations that patients
would receive on their iPhones or iPads. Ten patients undergoing routine cardiac
procedures were selected. Once securely registered, the patients’ instructions were
available on the app. Through the app, patients were prompted to read pre and post-
operative instructions. Patients also received speciﬁc reminders before and after their
procedure via push-notiﬁcations. The patients’ progress both pre and post-procedure
was sent to a newsfeed on a secured web portal, where physicians had full access.
After completing use of the app, patients were asked to complete an online survey.
The web portal and app were developed using a standard HIPAA compliant privacy
policy.
RESULTS 10 patients undergoing pacemaker implantation or Left Heart Catheteri-
zation were prospectively accrued. All 10 patients successfully registered with the
app, read and complied with instructions. There were no cancelled procedures or
post-operative complications.
CONCLUSION A smartphone app developed for perioperative care was used effec-
tively in a small cohort of 10 patients undergoing routine cardiology procedures. It
ensured 100% compliance with instructions along with excellent patient satisfaction
scores . The use of electronic instructions on a smartphone or tablet with built-in
reminders and the ability to send secure data to physicians could improve periop-
erative care, ensure compliance, and reduce post-operative complications. A larger
cohort of patients with long-term follow-up across various medical disciplines is
necessary to corroborate these ﬁndings.CRT-709
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BACKGROUND Accurate assessment of Cardiac Output (CO) is a critical measurement
in the cardiac catheterization laboratory (CCL), especially in calculation of aortic
valve area (AVA). Due to known inaccuracy of Fick assumptions, many measure
Thermodilution (TD) CO as well. Most physicians assume that this more accurate
measurement can be chosen to determine AVA. However, we have discovered that
our popular computer system [Philips Xper Connect (XIM)] will use predetermined
rules to assign one of the CO methods for the reported AVA.
METHODS We randomly selected one hundred consecutive patients who underwent
right and left heart catheterization from 2009-2012 for assessment of aortic valve
areas and had both Fick CO calculated using femoral and pulmonary arterial satura-
tions and thermodilution CO performed for calculation of AVA. We then examined
our XIMS system records for each of these procedures and documented the timingwhen each CO method was performed and reviewed which CO and AVA calculation
appeared on the ﬁnal catheterization report.
RESULTS We found that whichever CO calculation was done ﬁrst by the CCL com-
puter system became the determinative output, appearing on the ﬁnal report and
being used to calculate the ofﬁcial AVA. In 32 patients the CO and AVA were calcu-
lated and displayed using the Fick calculation method, which had been performed
ﬁrst, and in 68.
patients TD was performed ﬁrst and the AVA and CO were calculated and displayed
using this CO. Although the second CO type could be selected on the computer during
the case, and the computer screen would temporarily display the related AVA, this
would never appear in the ﬁnal report and may never be seen by the physician. Thus
the CO used ofﬁcially depended solely of the timing of the oxygen saturation samples.
An intense effort of 11 non-intuitive computer clicks and multiple screen changes is
required to make the second output the determinative value. The recommendation
for surgery (AVA <1.0 cm2) was different between the CO methods in 12 cases (12% of
patients).
CONCLUSION Our widely used computer system has an arbitrary method of selecting
the determinative CO to calculate the ﬁnal AVA. For the more accurate TD CO to
’trump’ the Fick CO an elaborate series of computer commands needs to be per-
formed. None of the physicians or technicians was aware of this computer selection
process, which affects critical treatment decisions.PERCUTANEOUS VALVE INTERVENTION
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BACKGROUND Transcatheter implantations of aortic valves (TAVR) have revolu-
tionized management of severe aortic stenosis. Speciﬁc complications have been
noted with ﬁrst-generation valves. Details of such were sought from the US Food and
Drug Administration (FDA) maintained MAUDE database which houses medical de-
vice reports submitted to the FDA by mandatory reporters (manufacturers, importers
and device user facilities) and voluntary reporters such as health care professionals,
patients and consumers.
METHODS A detailed search was conducted in PubMed, Cochrane Library, EMBASE
and CINAHL to identify adverse events reported with implantations of the ﬁrst gen-
eration Medtronic CoreValve(s). Then the FDA MAUDE database was queried from
January 2014 to August 31, 2014 to identify prevalence of the same complications as
reported to the FDA. Individual patient reports were identiﬁed and relevant data on
such complications were abstracted. Finally mortality outcomes from such patients
were abstracted, and associations of same for each individual reported complication
were identiﬁed in a multivariate logistic regression model.
RESULTS FDA MAUDE revealed 384 unique reports of complications with the ﬁrst
generation CoreValves. A total of 22 patients died peri-procedurally. The complica-
tions most strongly associated with peri-procedural mortality were development of
peri-procedural cardiogenic shock, ventricular tachycardia, development of post-
procedural atrial ﬁbrillation, acute renal failure and the need for valve-in-valve
procedure.(Table 1)
CONCLUSIONS Speciﬁc complications with the ﬁrst-generation Medtronic CoreValves
were strongly associated with mortality, and focused strategies to mitigate the same
may improve outcomes with future generations of this exciting new technology.
